Indian Scientists Devise 16 Disaster Management Drugs

Indian scientists have devised 16 drugs to use in certain disaster situations. These include an anti-cyanide drug, an anti-nerve gas drug, and an anti-toxic gas drug. The main goal for the scientists in developing these drugs: To prepare for future chemical, biological, radiological and nuclear (CBRN) incidents.

The Drug Controller General of India has approved the 16 as trial drugs, including several radioactive decorporation agents, according to a report by The drugs were developed by scientists at the Defence Research and Development Organisation (DRDO) Institute of Nuclear Medicine and Allied Sciences (INMAS) in New Delhi. According to official sources, all of the drugs have passed the efficacy test and will cost less than those currently available in the market.

These trial drugs will be used for disaster management by armed forces, the paramilitary, the National Disaster Management Authority (NDMA), the Department of Atomic Energy (DAE) and the Ministry of Health.

“Batch production of these drugs is being undertaken in collaboration with the pharmaceuticals industry through contract manufacturing. About 50,000-200,000 doses (licensed for human use) are expected to be manufactured by March 2013,” said Aseem Bhatnagar, who is in charge of the project at INMAS, as quoted by The drugs will be used for continuing clinical trials and for stockpiling.

Scientists specify that research, development and coordination will enhance the shelf life of nuclear, biological and chemical drugs by 60-100%.

For more information about these disaster management drugs, visit: